These compounds may interact with:
Nuclear receptor subfamily 5 group A member 2
Potentially involved in: osteoporosis; pancreatic cancer; carcinoma; kidney disease; crohn's disease; leydig cell tumor; cancer; dental caries; anovulation; female infertility; pancreatic neoplasm; adult high grade glioma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; colon cancer; glioblastoma; interstitial cystitis; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn)
Disease data sourced from Pharos.